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Glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)  is a key  glycolytic  enzyme  that  is predominantly
localized  in  the  cytoplasm.  However,  recent  studies  have  suggested  that  GAPDH  is  released  by various
cells  and  that  extracellular  GAPDH  is involved  in the  regulation  of  neuritogenesis  in neuronal  cells.  It has
also  been  reported  that  GAPDH  is expressed  on  the  surfaces  of  macrophages  and  functions  as a transferrin
receptor.  However,  since  GAPDH  is a leaderless  protein  the  mechanisms  by which  it reaches  the  extracel-
lular  environment  remain  unclear.  Here,  we  examined  the  role  of P2X7  receptor  (P2X7R),  an ATP-gated
cation  channel,  in the  unconventional  release  of  GAPDH  from  microglial  cells,  the  resident  macrophages
in  the brain.  The  activation  of P2X7R  by  ATP  triggered  GAPDH  release  from  lipopolysaccharide  (LPS)-
primed  microglial  cells.  ATP-induced  microvesicle  formation,  exosome  release,  and  K+ efﬂux  followed  by
caspase-1  activation  are  likely  involved  in the  GAPDH  release,  but ATP-induced  dilatation  of  membrane
pores  and  lysosome  exocytosis  are  not. It was also  demonstrated  that  exogenous  GAPDH  facilitated  LPS-
induced  phosphorylation  of  p38  MAP  kinase  in  microglial  cells.  These  ﬁndings  suggest that  P2X7R  plays
an  important  role  in  the  unconventional  release  of  GAPDH  from  microglial  cells,  and  the  GAPDH  released
into  the  extracellular  space  might  be involved  in the  regulation  of the  neuroinﬂammatory  response  in
the  brain.
© 2015  The  Authors.  Published  by Elsevier  B.V.  on  behalf  of European  Federation  of  Immunological
en  acSocieties.  This  is  an op
. Introduction
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of
he key enzymes involved in glycolysis, a metabolic pathway that
onverts glucose into pyruvate and generates the high-energy com-
ound ATP. In addition to this classical function, GAPDH has also
een demonstrated to be involved in numerous cellular processes
n mammalian cells [1,2]. Although GAPDH is generally considered
o be an intracellular protein because it lacks a signal sequence,
arious studies have detected GAPDH outside of cells and pro-
osed that GAPDH performs some of its biological functions in the
xtracellular space.
∗ Corresponding authors. Fax: +81 29 838 6043.
E-mail addresses: ttakenou@affrc.go.jp (T. Takenouchi), kitani@affrc.go.jp
H. Kitani).
ttp://dx.doi.org/10.1016/j.imlet.2015.08.002
165-2478/© 2015 The Authors. Published by Elsevier B.V. on behalf of European Federatio
icense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).cess  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Regarding the secretion of GAPDH by mammalian cells, extra-
cellular GAPDH has been detected in conditioned medium derived
from various cell lines including COS-7 and HEK293 cells [3]. It
has also been reported that GAPDH is expressed on the surfaces
of macrophages, which play important roles in the innate immune
system, and that it functions as a transferrin or lactoferrin receptor
[4–7]. In addition, macrophages have been demonstrated to secrete
high levels of GAPDH [5]. Despite these ﬁndings, the mechanisms
underlying the secretion of GAPDH from mammalian cells are still
poorly understood.
In macrophages, exogenous ATP activates unconventional
secretion pathways that result in the release of leaderless pro-
teins into the extracellular space [8]. The P2X7 receptor (P2X7R),
an ATP-gated cation channel that is highly expressed by mono-
cyte/macrophage lineage cells, plays a critical role in this process
[8]. In fact, the activation of P2X7R by ATP was found to markedly
stimulate the release of several intracellular proteins such as
n of Immunological Societies. This is an open access article under the CC BY-NC-ND
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ytokines or alarmins, e.g., interleukin-1 (IL-1) and high mobility
roup box protein 1 (HMGB1), from macrophages [8,9].
Recently, Makhina et al. reported that GAPDH is a binding part-
er for the cell adhesion molecule L1, and another study found
hat extracellular GAPDH participates in the regulation of neurite
utgrowth by modulating L1 phosphorylation [10,11]. However,
ery little is known about how extracellular GAPDH is generated in
he brain. In this regard, we speculate that microglia, the resident
acrophages in the brain, are candidates for the cells that pro-
uce extracellular GAPDH. To verify this, we investigated the role
f P2X7R in the unconventional release of GAPDH from microglial
ells. Our data suggest that P2X7R is responsible for the ATP-
nduced release of GAPDH from lipopolysaccharide (LPS)-primed
icroglial cells and that the GAPDH released into the extracellular
pace might be involved in the regulation of neuroinﬂammation
nd/or neuritogenesis in the brain.
. Materials and methods
.1. Materials
ATP, oxidized ATP (oxATP), LPS, brilliant blue-G (BBG), GAPDH
rom human erythrocytes (hGAPDH), and bovine serum albumin
BSA) were purchased from Sigma (St. Louis, MO). Flagellin was
urchased from InvivoGen (San Diego, CA). CuCl2 and A438079
ere obtained from Wako Pure Chemical Industries Ltd. (Osaka,
apan), and Tocris (Bristol, UK), respectively. Anti-cathepsin D
oat polyclonal, anti-P2X7R rabbit polyclonal, anti-GAPDH mouse
onoclonal, anti-CD63 rabbit polyclonal, and anti-lactate dehy-
rogenase A (LDH-A) rabbit polyclonal antibodies were acquired
rom Santa Cruz Biotechnology (Santa Cruz, CA), Alomone labs
Jerusalem, Israel), HyTest (Turku, Finland), System Biosciences
Mountain View, CA), and Novus Biologicals (Littleton, CO), respec-
ively. Mouse monoclonal antibodies against phospho-p44/42
itogen-activated protein kinase (MAPK) and phospho-p38 MAPK
nd rabbit polyclonal antibodies against nuclear factor (NF)-B
65 subunit, phospho-NF-B  p65, p44/42 MAPK, and p38 MAPK
ere purchased from Cell Signaling Technology, Inc. (Danvers, MA).
orseradish peroxidase (HRP)-conjugated rabbit anti-goat IgG and
oat anti-mouse Igs antibodies were obtained from ICN Pharma-
eutical, Inc. (Aurora, OH). HRP-conjugated goat anti-rabbit IgG
ntibody was purchased from Millipore (Bedford, MA). YO-PRO-
 iodide and Alexa Fluor 488 goat anti-mouse IgG antibody were
btained from Life Technologies (Carlsbad, CA). CF-594-conjugated
halloidin was obtained from Biotium, Inc. (Hayward, CA). Caspase-
 inhibitor II (Ac-YVAD-CMK), caspase-3 inhibitor, and pepstatin
-methyl ester were purchased from Merck-Biosciences (Bad
oden, Germany). Propidium iodide (PI) was obtained from Dojindo
aboratories (Kumamoto, Japan).
.2. MG6  and primary microglial cell cultures
c-Myc-immortalized mouse microglial MG6  cells (RCB 2403,
IKEN Cell Bank, Tsukuba, Japan), which were established in
ur previous study [12], were maintained in growth medium
omposed of Dulbecco’s modiﬁed Eagle’s medium (DMEM) con-
aining 10% fetal bovine serum supplemented with 100 M
-mercaptoethanol, 10 g/ml insulin, 100 g/ml streptomycin,
nd 100 U/ml penicillin in 100 mm Petri dishes (BD Falcon, Franklin
akes, NJ). Primary microglial cells were obtained from mixed brain
ell cultures derived from neonatal C57BL/6 mice, as described pre-
iously [13].Letters 167 (2015) 116–124 117
2.3. Immunoblotting
The microglial cell culture supernatants and cell lysates used
for the immunoblotting experiments were prepared as described
in our previous studies [13–15]. In brief, MG6  or primary microglial
cells (3 × 105/well in a 24-well plate) were primed with 1 g/ml
LPS for 4 h, before the medium was replaced with 250 l HEPES-
buffered salt solution (HBSS; 145 mM NaCl, 2.5 mM KCl, 1 mM
MgCl2, 1.8 mM CaCl2, 20 mM HEPES, 10 mM glucose, 0.01% BSA;
pH 7.4) containing the indicated test reagents. MG6  cells were also
pretreated with 100 ng/ml LPS or 100 ng/ml ﬂagellin for 4 h. To ana-
lyze the phosphorylation of MAPK, MG6  cells were incubated with
serum-free medium for 8 h, and then the medium was replaced
with 250 l HBSS containing the indicated test reagents. Neutral-
ized ATP stock solutions were prepared as described previously
[13]. To assess the effect of oxATP on GAPDH release, MG6  cells
were pretreated with oxATP during LPS treatment. Divalent cation-
free buffer was  prepared by removing the CaCl2 and MgCl2 from
the HBSS. A buffer containing a high concentration of extracellular
K+ (high K+) was  prepared by replacing all of the NaCl (145 mM)
with KCl. After the MG6  cells had been incubated at 37 ◦C for
30 min  or the indicated time, the culture supernatant was  collected,
and the cells were lysed with 200 l ice-cold lysis buffer [50 mM
Tris–HCl (pH 7.4), 150 mM NaCl, 0.5% Triton X-100, and 0.5% sodium
deoxycholate] containing complete mini protease inhibitor (Roche
Diagnostics, Basel, Switzerland) or complete mini plus PhosSTOP
tablets (Roche). Equal volumes of culture supernatant (20 l)
and cell lysate (4 l) were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS–PAGE) and electroblotted
onto polyvinylidene diﬂuoride membranes (Millipore). After being
treated with Blocking One (Nakalai Tesque, Kyoto, Japan), the mem-
branes were incubated with the primary antibodies in TBST for 1 h,
before being incubated with HRP-conjugated secondary antibodies
for 1 h. The target proteins were revealed using a Chemi-Lumi One
Super kit (Nakalai Tesque), Immunostar LD (Wako) or ECL Select
kit (GE Healthcare, Piscataway, NJ), and detected on X-ray ﬁlm (GE
Healthcare) or using a c-Digit Blot Scanner (LI-COR, Inc., Lincoln,
NE). A quantitative analysis of the intensity of the bands produced
by immunoblotting was  performed using the image processing
software ImageJ 1.38 v (NIH, USA) for Macintosh.
2.4. Measurement of GAPDH activity and ELISA analysis of
GAPDH release
MG6  cells (3 × 105/well in a 24-well plate) were incubated in
the presence or absence of 1 g/ml LPS for 4 h. Then, they were
stimulated with ATP for 30 min  in 250 l HBSS, and their super-
natants were collected. To prepare the cell extract, the cells were
lysed with 1 ml  of KDalertTM lysis buffer. Both the supernatant and
cell lysate were used to assess GAPDH activity, and neither of them
was frozen before the experiments. Either 10 l supernatant or 2 l
lysate diluted to 10 l with HBSS was  analyzed for GAPDH activ-
ity using the KDalertTM GAPDH assay kit (Life Technologies). The
resultant data are expressed as percentages of the total cytosolic
GAPDH activity observed in the LPS-treated or LPS-untreated MG6
cell lysate.
In addition, the amounts of GAPDH protein contained in the
supernatants or lysates of LPS-primed MG6  cells were determined
using a sandwich ELISA according to the manufacturer’s instruc-
tions (DuoSet IC, Human/Mouse/Rat Total GAPDH ELISA kit, R&D
Systems). ATP-induced GAPDH release is expressed as a percent-
age relative to the total amount of cytosolic GAPDH obtained from
the ATP-untreated LPS-primed MG6  cell lysate.
118 T. Takenouchi et al. / Immunology Letters 167 (2015) 116–124
Fig. 1. ATP-induced release of GAPDH from LPS-primed MG6  cells. LPS-treated and LPS-untreated MG6  cells were stimulated with ATP at the indicated concentrations. The
resultant culture supernatants (Sup) and cell lysates were analyzed by immunoblotting using antibodies against GAPDH and P2X7R. At 30 min after the ATP stimulation,
increased release of GAPDH into the culture supernatant was observed in the LPS-primed MG6  cells compared with the LPS-untreated cells (A). The expression levels of
GAPDH  and P2X7R were not changed by LPS priming (A). ELISA analysis revealed that the amounts of GAPDH released into the supernatants after ATP stimulation are around
1–2%  of total cytosolic GAPDH protein in the LPS-primed MG6  cells (B). Four independent experiments were performed, and the data are shown as mean ± SEM values
(B).  The facilitation of ATP-induced GAPDH release was  not observed in MG6  cells pretreated with ﬂagellin (C). ATP-induced GAPDH release occurred in a time-dependent
manner in the LPS-primed MG6  cells (D). The intensities of the bands corresponding to GAPDH were quantiﬁed, and the results are expressed as percentages relative to the
values obtained for the cells treated with 2 mM or 4 mM of ATP for 30 min  (D). Increased GAPDH activity was  detected in the culture supernatant of the MG6  cells at 30 min
after  ATP stimulation (E). The data are expressed as a percentage of the total cytosolic GAPDH activity observed in the LPS-treated or LPS-untreated MG6  cell lysate (E).
Four  independent experiments were performed, and the data are shown as mean ± SEM values (*p < 0.05, **p  < 0.01 vs. untreated control) (E). CuCl2 and P2X7R antagonists
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CA438079, BBG, and oxATP) inhibited ATP-induced GAPDH release from LPS-prime
elease  induced by P2X7R agonist BzATP from the LPS-primed MG6  cells (G).
.5. Immunocytochemistry
MG6  cells were seeded in 8-well chamber slides (Asahi Glass Co.
td., Tokyo, Japan) (1 × 105 cells/well). The next day, the cells were
ncubated in the presence or absence of 1 g/ml LPS for 4 h. Then,
hey were stimulated with ATP for 30 min  in HBSS, before being
xed with 4% paraformaldehyde phosphate buffer solution (Nacalai
esque) for 15 min  at room temperature. After being washed with
BS containing 0.05% Tween 20 (PBST), the cells were perme-
bilized with 1% Triton X-100/PBS solution for 10 min  and then
locked with Blocking One Histo (Nacalai Tesque) for 30 min. Next,
he cells were incubated with anti-GAPDH antibody (1:400) for
 h, before being incubated with Alexa Fluor 488 goat anti-mouse
gG antibody (1:400) and CF-594-conjugated phalloidin (1:400)
or 1 h. The immunostained cells were mounted using ProLong
old antifade reagent with DAPI (Life Technologies) and observed
sing an inverted ﬂuorescence microscope (Olympus IX-81). In
ach experiment, Z-stack images of the cells were produced from
ore than 30 images taken at 0.2 m intervals using a CCD camera
Retiga-SRV, Q-imaging Co., Surrey, BC, Canada) controlled by the
oftware MetaMorph. The z-stack images were deconvoluted using 3D blind deconvolution algorithm (AutoQuant X software, Media
ybernetics, Bethesda, MD). cells (F). The depletion of divalent cations (Ca2+, Mg2+-free) enhanced the GAPDH
2.6. Isolation of exosomes
MG6  cells (3 × 105/well in a 24-well plate) primed with LPS
(1 g/ml) for 4 h were stimulated with ATP for 30 min  in 250 l
HBSS. Their supernatants were collected, and centrifuged for
20 min  at 1200 g to eliminate detached intact cells and large debris.
The supernatants (16 l) were used as exosome-containing super-
natant fractions. In addition, the supernatants (200 l) were further
centrifuged for 1 h at 10,000 g (AF-2018 rotor, Kubota, Tokyo,
Japan), and the pellets were used as microvesicle-enriched frac-
tions. Then, 100 l Exosome Isolation Reagent (Life Technologies)
was added into each resultant supernatant. The reagent-treated
supernatants were incubated at 4 ◦C overnight and centrifuged for
1 h at 10,000 g. The resultant pellets and supernatants (24 l) were
used as exosome-enriched fractions and exosome-depleted super-
natant fractions, respectively. Each fraction was  resolved using
SDS–PAGE and analyzed by immunoblotting.
2.7. Dye uptake assay
MG6  cells (3 × 105) were seeded into 35 mm glass-bottomed
dishes. The next day, the cells were treated with or without 1 g/ml
LPS for 4 h and then incubated with HBSS containing 10 M PI and
10 M YO-PRO-1 at pH 7.4 or pH 6.2. After the cells had been incu-
bated at 37 ◦C for 15 min, 4 mM ATP were added, and the cells were
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ubjected to time-lapse recording for a further 30 min  using an
nverted ﬂuorescence microscope (Olympus IX-81, Tokyo, Japan).
he photographs captured during the time-lapse recording, each
f which contained around 250 cells, were subsequently used for
uantitative analyses. The intensity of the dye-derived ﬂuorescence
hown on the images was quantiﬁed, and the mean ﬂuorescence
ntensity of the each image was calculated using the software
etaMorph (Molecular Devices, Downingtown, PA). The data are
xpressed in arbitrary units and represent the mean ± SEM values
f three independent experiments.
.8. Statistics
Data are shown as mean ± SEM values. Mean values were ana-
yzed with one-way ANOVA followed by Dunnett’s post-hoc test
sing the software Instat 3 for Macintosh. Statistical signiﬁcance
as set at p < 0.05.
. Results
.1. ATP induces GAPDH release from LPS-primed MG6  cells
hrough P2X7R activation
We  found that exogenous ATP triggers the release of GAPDH
rom MG6  cells into the culture supernatant. High concentrations
f ATP (in the mM range) were required to induce GAPDH release
Fig. 1A). LPS priming markedly facilitated ATP-induced GAPDH
elease from MG6  cells, but did not affect the protein expression
evels of GAPDH or P2X7R (Fig. 1A). Since GAPDH is abundantly
ontained in cell lysates, immunoblotting of cell lysates was  basi-
ally performed with short exposure time periods (∼20 s) to obtain
ppropriate signal intensity of GAPDH compared to that of cul-
ig. 2. ATP-induced microvesicle formation and F-actin rearrangement in LPS-primed MG
f  ATP for 30 min, before being ﬁxed with paraformaldehyde. The morphology of the cel
-actin,  and nuclei were visualized using an anti-GAPDH antibody that is recognized by
API  (blue), respectively. Stimulation with ATP induced the formation of microvesicle-lik
G6  cells (A, some of them are indicated by white arrows). The microvesicles were frequ
rom  each cell body (A). The ATP-induced formation of GAPDH-containing microvesicles 
re  shown. Bar = 20 m. (For interpretation of the references to color in this ﬁgure legendLetters 167 (2015) 116–124 119
ture supernatants [longer exposure times (∼10 min) were required
for immunoblotting of supernatants]. Therefore, to quantitatively
compare the amounts of GAPDH, ELISA analysis has been performed
on cell lysates and culture supernatants of LPS-primed MG6  cells.
The results showed that total 146.88 ± 9.31 ng of GAPDH was  con-
tained in ATP-untreated cell lysates, while 0.16 ± 0.08, 1.82 ± 0.71,
and 2.40 ± 0.63 ng of GAPDH were contained in supernatants after
stimulations with 0, 2, and 4 mM of ATP, respectively. Based on
these data, it was  shown that around 1–2% of the total cytosolic
GAPDH protein was  released into the culture supernatant after
stimulation with 2 mM or 4 mM of ATP in LPS-primed MG6  cells
(Fig. 1B). In contrast to the ﬁnding with LPS [the ligand for Toll-
like receptor 4 (TLR4)], pretreatment with bacterial ﬂagellin (the
ligand for TLR5) did not facilitate the GAPDH release induced by
ATP from MG6  cells (Fig. 1C), suggesting that LPS-dependent cel-
lular responses are required for the induction of the facilitation of
ATP-induced GAPDH release. GAPDH was detected in the culture
supernatant at 20 min  after ATP stimulation, and GAPDH release
plateaued after 30 min  incubation (Fig. 1D). Stimulation with 4 mM
ATP slightly accelerated the initiation of GAPDH release compared
with that induced by stimulation with 2 mM ATP (Fig. 1 D). The
administration of ATP (3–5 mM)  also induced an increase in GAPDH
activity in the MG6  cell culture supernatant (Fig. 1E). Consistent
with the facilitation of GAPDH release, LPS priming enhanced the
ATP-induced increase in extracellular GAPDH activity (Fig. 1E). The
increase in GAPDH activity observed in the culture supernatant of
the LPS-primed MG6  cells stimulated with 2 mM ATP was  negligible
(Fig. 1E), even though a sufﬁcient amount of GAPDH was present
(Fig. 1A).To determine the involvement of P2X7R in ATP-induced GAPDH
release, the effects of three different P2X7R antagonists (A438079,
BBG, and oxATP); CuCl2, which is an inhibitor of P2X7R [12,16];
6  cells. LPS-treated and LPS-untreated MG6  cells were stimulated with 2 or 4 mM
ls was observed using differential interference contrast (DIC) microscopy. GAPDH,
 Alexa Fluor 488 anti-mouse IgG (green), CF-594-conjugated phalloidin (red), and
e structures, which were positively immunostained for GAPDH, in the LPS-primed
ently observed together with F-actin-containing processes that extended radially
was reduced in the LPS-untreated MG6  cells (B). Deconvoluted images of the cells
, the reader is referred to the web version of this article.)
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nd BzATP, a potent P2X7R agonist, were examined in LPS-primed
G6  cells. The GAPDH release induced by 2 mM ATP was  blocked
y treatment with the P2X7R antagonists or CuCl2 (Fig. 1F). Robust
APDH release was observed when the cells were stimulated with
zATP (200–1000 M)  in divalent cation-free buffer (Fig. 1G). This
s because divalent cations steadily suppress the functions of P2X7R
y directly modulating it [16]. Collectively, these results support the
otion that P2X7R activation is involved in ATP-induced GAPDH
elease from LPS-primed MG6  cells.
.2. Microvesicle formation and exosome release are associated
ith ATP-induced GAPDH release
It was reported that P2X7R activation triggers the formation
f microvesicles (100–1000 nm in diameter) via shedding from
he plasma membrane in monocyte/macrophage lineage cells [17].
icrovesicle shedding seems to play an important role in the
nconventional release of leaderless cytosolic proteins including
L-1 [17]. Microvesicle-like structures that had been immuno-
tained with anti-GAPDH antibody were observed around the
PS-primed MG6  cells after ATP stimulation (Fig. 2A, white arrows).
he microvesicles were frequently observed together with F-actin-
ontaining processes that radially extended from each cell body
Fig. 2A). In contrast, the extension of F-actin-containing processes
nd formation of GAPDH-containing microvesicles induced by ATP
ig. 3. Detection of GAPDH in microvesicle and exosome-enriched fractions obtained fro
ells  were stimulated with 2 or 4 mM of ATP for 30 min. The supernatants were collec
xosome-depleted supernatant, and exosome-containing supernatant fractions. These fr
nd  LDH-A. Exosomal marker protein CD63 was  mainly detected in exosome-enriched pe
lots).  GAPDH was  detected in both microvesicle-enriched and exosome-enriched pelle
lots,  and B). In contrast, LDH-A was clearly remained in exosome-depleted supernatan
middle three blots in A) were quantiﬁed, and the results are expressed as percentages rel
r  exosome-containing supernatant fraction (lower graph) of the cells stimulated with 4 Letters 167 (2015) 116–124
were clearly reduced in the LPS-untreated MG6  cells (Fig. 2B). In
addition, GAPDH was also detected in the microvesicle-enriched
pellet fractions that were obtained from the supernatants of ATP-
stimulated LPS-primed MG6  cells (Fig. 3A, middle blots, and B).
These results suggest that ATP-induced microvesicle formation
contributes to the unconventional release of GAPDH into the extra-
cellular space.
Exosomes are extracellular vesicles of 50–100 nm in diameter
that transmit membrane/cytoplasmic proteins, RNAs, and informa-
tion from cell to cell. P2X7R activation by ATP is known to induce
exosome release from macrophages via exocytosis of multivesic-
ular endosome [8,9]. Thus, we  examined whether ATP-induced
exosome release is involved in the GAPDH release from LPS-primed
MG6  cells. Exosomal marker protein CD63 was  predominantly
detected in exosome-enriched pellet fractions (Fig. 3A, upper blots),
indicating that exosomes are certainly recovered in these fractions.
Notably, GAPDH was  also detected in exosome-enriched fractions,
and clearly diminished in exosome-depleted supernatant fractions
(Fig. 3A, middle blots, and B). In contrast, cytosolic protein LDH-A, a
marker of cell damage, was  not concentrated in exosome-enriched
fractions, and dominantly detected in supernatant fractions even
after exosome depletion (Fig. 3A, lower blots). Therefore, it is
likely that ATP-induced exosome release is also associated with
the GAPDH release.
m supernatants of LPS-primed MG6  cells after ATP stimulation. LPS-primed MG6
ted, and fractionated into microvesicle-enriched pellet, exosome-enriched pellet,
actions were analyzed by immunoblotting using antibodies against CD63, GAPDH,
llet fractions, and diminished in exosome-depleted supernatant fractions (A, upper
t fractions, and diminished in exosome-depleted supernatant fractions (A, middle
t fractions (A, lower blots). The intensities of the bands corresponding to GAPDH
ative to the values obtained for the exosome-enriched pellet fraction (upper graph)
mM ATP (B). The data are shown as mean ± SEM values (B).
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.3. ATP-induced K+ efﬂux followed by caspase-1 activation
egulates GAPDH release
It is worth noting that ATP-induced GAPDH release from
PS-primed MG6  cells was abolished in the presence of higher
oncentrations of extracellular K+ (Fig. 4A), suggesting that P2X7R-
ediated K+ efﬂux from the cells plays a critical role in this
rocess. To further assess the role of K+ efﬂux, we  tested the
ffects of nigericin, a K+/H+ ionophore, on GAPDH release from
PS-primed MG6  cells. Nigericin is known to elicit K+ efﬂux, which
n turn induces the maturation and release of IL-1 from mono-
ytes/macrophages [18,19]. As expected, nigericin triggered the
elease of GAPDH, but this effect was abolished by incubating the
ells in a high K+-containing buffer (Fig. 4A).
Since high K+-containing buffer was found to block the P2X7R-
ediated activation of caspase-1 [14,20], a caspase-1 inhibitor was
sed to examine the role of active caspase-1 in ATP-induced GAPDH
elease. The caspase-1 inhibitor signiﬁcantly suppressed the ATP-
nduced release of GAPDH, whereas treatment with a caspase-3
nhibitor or pepstatin-A, a cathepsin D inhibitor, did not (Fig. 4B).
s was found in a previous study [21], active caspase-1 might be
nvolved in regulating the ATP-induced unconventional release of
APDH from LPS-primed MG6  cells.
.4. ATP-induced dilatation of membrane pores and lysosome
xocytosis are not associated with GAPDH release
The sustained activation of P2X7R by ATP results in the dilata-
ion of membrane pores followed by cytolysis in microglial cells
22]. So, we attempted to examine the association between GAPDH
elease and pore dilatation after ATP stimulation in microglial
ells. ATP-induced pore formation was evaluated by the uptake of
I and YO-PRO-1 dyes. YO-PRO-12+ (MW  = 375 Da) readily passes
hrough the P2X7R-associated membrane pore, but propidium2+
MW  = 414 Da) does not. Indeed, YO-PRO-1 was  incorporated into
PS-untreated and treated MG6  cells within 30 min  after stimula-
ig. 4. Suppressive effects of extracellular high K+ and caspase-1 inhibitor on ATP-induced
ith  ATP or nigericin at the indicated concentrations for 30 min, and the resultant culture
nduced GAPDH release was abolished by incubating the cells in a high K+-containing 
nhibited by high K+-containing buffer (A). Caspase-1 inhibitor suppressed ATP-induced G
f  the bands corresponding to GAPDH were quantiﬁed in three independent experiments,
ontrol  cells stimulated with 5 mM ATP (B). The data are shown as mean ± SEM values (*pLetters 167 (2015) 116–124 121
tion with 4 mM ATP at extracellular pH of 7.4 and 6.2 (Fig. 5A).
In contrast, the marginal uptake of PI dye was detected in
LPS-untreated MG6  cells stimulated with 4 mM ATP at both extra-
cellular pHs (Fig. 5B). The ATP-induced PI uptake was slightly
increased in the LPS-primed MG6  cells at pH 7.4 (Fig. 5B), suggest-
ing that ATP-induced pore dilatation occurs very slowly in these
cells. This implies that the association between ATP-induced pore
dilatation and GAPDH release is weak under physiological condi-
tions.
Furthermore, we demonstrated that the ATP-induced uptake of
PI into LPS-primed MG6  cells was  dramatically enhanced at pH 6.2
compared with that observed at pH 7.4 (Fig. 5B). This indicates that
the number of dilated membrane pores was markedly increased at
pH 6.2. However, we found that ATP-induced GAPDH release from
LPS-primed MG6  cells was  conversely reduced at an extracellular
pH of 6.2 compared with that observed at an extracellular pH of 7.4
(Fig. 5C). Similarly, ATP-induced GAPDH release was observed at pH
7.4, but abolished at pH 6.2, in the LPS-primed primary microglia
(Fig. 5C). Thus, these ﬁndings further support our conclusion that
ATP-induced pore dilatation is not associated with the induction of
GAPDH release.
Consistent with the ﬁndings of our previous study [13], we also
demonstrated that a signiﬁcant amount of cathepsin D was released
from the LPS-primed MG6  cells and primary microglia after ATP
stimulation at extracellular pH of 7.4 and 6.2 (Fig. 5C). Since cathep-
sin D release from macrophage lineage cells is indicative of the
induction of secretory lysosome exocytosis [23], this suggests that
ATP-induced lysosome exocytosis is not associated with GAPDH
release.
3.5. Exogenous GAPDH facilitates the LPS-induced
phosphorylation of p38 MAPK in MG6 cellsWe further examined whether exogenous GAPDH affects intra-
cellular signaling pathways in microglial cells. The application
of hGAPDH alone had no effect on the phosphorylation of p38
 GAPDH release from LPS-primed MG6 cells. LPS-primed MG6  cells were stimulated
 supernatants were analyzed by immunoblotting using anti-GAPDH antibody. ATP-
buffer (A). Nigericin dose-dependently elicited GAPDH release, but that was also
APDH release, but caspase-3 inhibitor and pepstatin A did not (B). The intensities
 and the results are expressed as percentages relative to the values obtained for the
 < 0.05, **p < 0.01 vs. positive control) (B).
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Fig. 5. Effects of extracellular pH on the ATP-induced dilatation of membrane pores and GAPDH release from LPS-primed microglial cells. Dye uptake was monitored in
live  MG6  cells at 30 min  after stimulation with 4 mM ATP using ﬂuorescence microscopy. ATP-induced YO-PRO-1 uptake was  signiﬁcantly detected in LPS-untreated and
LPS-treated MG6  cells at extracellular pH of 7.4 and 6.2 (A). In contrast, marginal uptake of PI was  induced by ATP stimulation in the LPS-untreated MG6  cells at both pH
values  (B). In the LPS-primed MG6  cells, ATP-induced PI uptake was  markedly enhanced at pH 6.2 compared with that observed at pH 7.4 (B). The cells were permeabilized
by  treatment with 0.2% Triton X-100 to calibrate the maximum dye uptake (B). The YO-PRO-1 or PI-derived ﬂuorescence is expressed in arbitrary units, and the data are
shown  as the mean ± SEM values of three independent experiments. LPS-primed MG6  cells and primary microglia were stimulated with ATP at the indicated concentrations
for  30 min, and the resultant culture supernatants were analyzed by immunoblotting using antibodies against GAPDH and cathepsin D. ATP-induced GAPDH release was
reduced at pH 6.2 compared with that observed at pH 7.4 in these microglial cells (C). However, ATP-induced release of cathepsin D (46 kDa intermediate form) was  similarly
observed at both pH values (C).
Fig. 6. Facilitation of LPS-induced p38 MAPK phosphorylation by exogenous hGAPDH in MG6 cells. MG6  cells were incubated in serum-free medium for 8 h and then stimulated
with  LPS alone or LPS plus hGAPDH for 30 min  at the indicated concentrations. The cell lysates were analyzed by immunoblotting using antibodies against phospho-p38
MAPK, p38 MAPK, phospho-p44/42 MAPK, p44/42 MAPK, phospho-NF-B p65, and NF-B p65. LPS stimulation induced the phosphorylation of p38 MAPK, p44/42 MAPK, and
NF-B  p65 in a dose-dependent manner. Treatment with hGAPDH alone had no effect on the phosphorylation of these proteins at the indicated concentrations. Treatment
with  10 ng/ml LPS was insufﬁcient to induce p38 MAPK phosphorylation, whereas the co-application of hGAPDH and 10 ng/ml LPS induced p38 MAPK phosphorylation. The
addition of hGAPDH had marginal effects on the LPS-induced phosphorylation of p44/42 MAPK and NF-B p65.
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APK, p44/42 MAPK, or NF-B p65 in MG6  cells (Fig. 6). However,
PS treatment induced the phosphorylation of these proteins in
 dose-dependent manner (Fig. 6). Treatment with 10 ng/ml LPS
lone did not induce p38 MAPK phosphorylation, but co-treatment
ith hGAPDH and 10 ng/ml LPS induced an increase in p38 MAPK
hosphorylation (Fig. 6). The effect of hGAPDH on the p38 MAPK
hosphorylation induced by higher concentrations of LPS (50 and
00 ng/ml) was negligible (Fig. 6). No facilitative effect of hGAPDH
n the LPS-induced phosphorylation of p44/42 MAPK and NF-B
65 was observed (Fig. 6). These ﬁndings suggest the possibility
hat among the intracellular signaling pathways activated by LPS
n microglial cells released GAPDH affects the p38 MAPK pathway.
. Discussion
In this study, we demonstrated that ATP markedly induces
APDH release from LPS-primed microglial cells via P2X7R acti-
ation. It is likely that the ATP-induced microvesicle formation
nd exosome release contribute to the release of GAPDH. P2X7R-
ediated K+ efﬂux followed by the activation of caspase-1 plays
 critical role in the regulation of GAPDH release. In addition,
xogenous GAPDH has been shown to modulate the LPS-induced
ctivation of p38 MAPK in MG6  cells, implying that released GAPDH
s involved in the regulation of microglial cell activation. This study
rovides new insights into the release pathway and biological func-
ion of GAPDH in microglial cells.
We had initially expected that the P2X7R-mediated dilatation
f membrane pores might contribute to the induction of GAPDH
elease from LPS-primed microglial cells. However, only slight
ptake of PI into LPS-primed microglial cells was observed after ATP
timulation at physiological pH (7.4), indicating that ATP-induced
ore dilatation occurs very slowly under physiological conditions.
t was further demonstrated that ATP-induced pore dilatation is
acilitated, while ATP-induced GAPDH release is conversely sup-
ressed, at acidic extracellular pH (6.2). These ﬁndings support
he notion that ATP-induced pore dilatation is not associated with
trong GAPDH release. Therefore, we concluded that ATP-induced
APDH release from microglial cells is not merely due to leakage
hrough enlarged membrane pores.
It has been demonstrated that P2X7R-mediated K+ efﬂux plays
 critical role for the ATP-induced GAPDH release from LPS-
rimed MG6  cells. The depletion of intracellular K+ following K+
fﬂux through P2X7R channels leads to the activation of caspase-
 through the assembly of NLRP3 inﬂammasome, a multiprotein
ignaling complex of the innate immune system [24]. In fact, it
as also been shown that caspase-1 inhibitor suppressed the ATP-
nduced GAPDH release from LPS-primed MG6  cells, suggesting
hat enzymatic activity of caspase-1 is involved in this event. In
his context, Keller et al. reported that active caspase-1 is a regu-
ator of unconventional secretion of the leaderless proteins, such
s IL-1 and ﬁbroblast growth factor (FGF)-2 [21]. They suggested
hat active caspase-1 binds to IL-1/FGF-2, and acts as a carrier
n an ER/Golgi-independent protein secretion pathway [21]. Since
heir secretome analysis also identiﬁed GAPDH as a protein that
s secreted in a caspase-1-dependent manner [21], it is reasonable
o speculate that protein interaction between GAPDH and active
aspase-1 might be involved in the ATP-induced unconventional
elease of GAPDH from LPS-primed MG6  cells. Further experiments
ill be required to verify this possibility.
Although only small amounts of GAPDH were released into the
ulture supernatant by LPS-untreated MG6  cells that had been
timulated with 3–5 mM ATP (Fig. 1A), a signiﬁcant increase in
APDH activity was detected in the supernatant of these cells
Fig. 1C). In contrast, a signiﬁcant amount of GAPDH was detected
n the culture supernatant of the LPS-primed MG6  cells that wereLetters 167 (2015) 116–124 123
stimulated with 2 mM ATP (Fig. 1A), but the increase in the GAPDH
activity of the latter supernatant was  negligible (Fig. 1C). It is plau-
sible that the GAPDH released after ATP stimulation includes both
active and inactive forms, which would explain this discrepancy.
As LPS-primed MG6  cells generate large amounts of nitric oxide
[25], it has been speculated that some GAPDH is inactivated via s-
nitrosylation of the cysteine residue in the molecule’s active site
[26]. However, it still remains unclear why the inactive form of
GAPDH is preferentially released from LPS-primed MG6  cells upon
stimulation with 2 mM ATP.
The GAPDH protein is highly conserved across various species.
GAPDH is found on the outer surfaces of, or as a secretory prod-
uct in, various pathogenic organisms such as bacteria, fungi, and
protozoa [27–30]. In addition, accumulating evidence suggests that
GAPDH plays a role as a virulence factor in a number of pathogens
[31]. Also, GAPDH derived from pathogenic organisms seems to
modulate the host immune system to protect such organisms from
host defense mechanisms [28,30,32]. Given the strong homology
between pathogenic and mammalian GAPDH, GAPDH derived from
mammals might also act to modulate the mammalian immune sys-
tem. In this context, we provide intriguing evidence that exogenous
GAPDH affects the LPS-induced activation of the p38 MAPK path-
way in microglial cells. This ﬁnding raises the possibility that the
GAPDH released from microglia plays a role in the innate immune
system-associated neuroinﬂammatory reactions that occur in the
brain.
The mechanisms how exogenous GAPDH facilitates the LPS-
induced p38 MAPK activation in microglial cells still remain
unclear. Given that TLR4 activation by LPS stimulates multiple
intracellular signaling pathways (e.g., NF-B, MAPK, and inter-
feron regulatory factor 3 pathways) [33], it is unlikely that GAPDH
directly modulates TLR4 molecules because the facilitative effect
of GAPDH on LPS stimulation was preferentially observed in p38
MAPK pathway, but not in p44/42 MAPK and NF-B pathways. It is
well known that p38 MAPK works as a sensor of external stresses
and plays an essential role in regulating inﬂammation [34]. Based
on this ﬁnding, it is speculated that exogenous GAPDH might be
recognized as a stressor, which results in the preferential modu-
lation of the LPS-induced activation of p38 MAPK. Alternatively,
exogenous GAPDH may  affect the stress-dependent signaling path-
ways possibly through a cell-surface receptor in microglial cells.
Although cell adhesion molecule L1 and E-cadherin are reported
as candidate receptors for GAPDH in neuronal and gastric can-
cer cells, respectively [11,35], it is unclear whether these proteins
are expressed in microglial cells. Future studies are needed to
clarify the mechanism by which exogenous GAPDH modulates LPS-
induced activation of p38 MAPK, and the biological signiﬁcance of
the GAPDH/LPS co-signaling during inﬂammation.
Recently, N-terminal fragments of GAPDH have been iden-
tiﬁed as antimicrobial peptides from the skin of yellowﬁn and
skipjack tuna [36,37] or suggested [38]. In addition, an hGAPDH-
derived peptide was  demonstrated to possess tissue protective
immunomodulatory activity [38]. These studies have proposed that
GAPDH serves as a host defense substance in the innate immune
systems of vertebrates. It is also suggested that the proteolytic
degradation of extracellular hGAPDH by a pathogen or host might
lead to the generation of smaller peptides with antimicrobial activ-
ity [38]. If this is true, our study provides the novel insight that
P2X7R is an important target for the regulation of the production
of GAPDH-derived antimicrobial peptides as well as GAPDH release.Acknowledgements
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